Skip to content
Back to meeting Original
Dr Riyaz Shah· @DrRiyazShah · X·· 1 day agoScore70
Body · original

KRASCENDO 1: diva v soto/adag; off inhibitor; pretreated; n338: PFS HR 0.58; 4.1m longer mPFS; OS HR 0.56; 5.7m longer OS; mDOR 11.9m ORR 58%; CNS activity not as deep; #ESMO26 @BTOGORG

38 views · 1 like · 1 repost · 0 replies

Conference abstracts

Source: Dr Riyaz Shah · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website’s feedback page.